ASH1L and posterior cortical atrophy: Immunohistochemistry (IHC) staining of ASH1L in human PCa tumors revealed that ASH1L protein levels were positively correlated with cancer progression and aggressiveness (Fig. 1b and Supplementary Fig. 1e).